| Financial Year |
March 31 2023 |
| Monetary Funds |
3,820,982,617.25 |
| Held-for-trading Financial Assets |
422,982,889.34 |
| Notes Receivable |
80,113,242.35 |
| Accounts Receivable |
1,752,540,809.82 |
| Advances to Suppliers |
390,154,408.19 |
| Other Receivables |
104,261,697.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,951,674,265.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
424,089,182.72 |
| Other Current Assets |
357,151,270.96 |
| Total Current Assets |
11,056,848,156.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
260,034,048.04 |
| Long-term Equity Investment |
3,305,392,959.67 |
| Investment Properties |
-- |
| Fixed Assetes |
3,351,172,264.30 |
| Under-construction Projects |
699,828,362.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
863,150,100.63 |
| R&D expenses |
-- |
| Goodwill |
913,229,150.98 |
| Long-Term Deferred and Prepaid Expenses |
18,037,160.31 |
| Deferred Income Tax Assets |
201,096,569.13 |
| Other Non-Current Assets |
127,585,443.30 |
| Sub-Total of Non-Current Assets |
10,895,115,187.06 |
| Total Assets |
21,951,963,343.87 |
| Short-Term Loans |
1,078,481,759.37 |
| Trading Financial liabilities |
2,422,168.84 |
| Notes Payable |
550,470,317.01 |
| Accounts Payable |
1,412,062,886.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
75,112,837.15 |
| Taxes Payable |
108,284,567.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
169,361,541.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
648,875,735.84 |
| Other Current Liabilities |
138,580,692.78 |
| Sub-Total of Current Liabilities |
5,465,763,625.60 |
| Long-term Loans |
2,501,034,035.14 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
188,699,684.05 |
| Deferred Income Tax Liabilities |
13,567,230.86 |
| Other Non-Current Liabilities |
15,426,750.02 |
| Sub-Total of Non-Current Liabilities |
2,769,918,248.27 |
| Total Liabilities |
8,235,681,873.87 |
| Paid-In Capital(Or Share Stock) |
1,948,419,929.00 |
| Capital Surplus |
3,035,566,868.33 |
| Surplus Reserve |
396,165,018.95 |
| LESS:Treasury Stock |
500,000,213.13 |
| Undistributed Profits |
7,086,720,954.12 |
| Minority Stockholder's Interest |
2,155,989,444.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,560,292,025.45 |
| Owner's Equity（Stockholder's Equity） |
13,716,281,470.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,951,963,343.87 |
